16 results
6-K
CNTB
Connect Biopharma Holdings Ltd
12 Sep 23
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
4:47pm
and development activities, (4) expenses to develop our product candidates, including raw materials and supplies, product testing, manufacturing services
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
23 Jun 23
House Lease Contract
4:31pm
, gunpowder, narcotics and intermediates, medical raw materials, drugs, etc., as well as products that must be produced only after the production permit
6-K
CNTB
Connect Biopharma Holdings Ltd
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm
related expenses of personnel engaged in research and development activities, (4) expenses to develop our product candidates, including raw materials
20-F
EX-4.12
qshhl 99mixh3
31 Mar 22
Annual report (foreign)
4:33pm
20-F
n96d3sz p6ijoc6c6xmd
31 Mar 22
Annual report (foreign)
4:33pm
6-K
EX-99.2
g4x6z4r 51vp
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
424B4
b208b80bt
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
geapd fwqmr99
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
hu0c 1jgg5o
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
EX-10.10
7mraxde7y9g8e7zn
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
v8sr28zt 2mh97
26 Feb 21
Registration statement (foreign)
4:56pm
DRS/A
7e0 thfvbgdo8
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
pzxtcr7t7ipj7
17 Dec 20
Draft registration statement
12:00am
DRS
EX-10.7
w83 6nxm62i
17 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next